- Exchange: SIX Swiss Ex
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Medical Products
Snapshot for Synthes Inc (SYST)
| Open: | 158.200 | Day's Range: | 157.800 - 158.700 | Volume: | 126,987 | Bid: | 158.000 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 158.000 | 52wk Range: | 126.300 - 159.200 | 1-Yr Rtn: | +7.77% | Ask: | 158.100 |
Key Statistics for SYST
| Current P/E Ratio (ttm) | 20.1623 |
|---|---|
| Estimated P/E (12/2012) | 19.5921 |
| Earnings Per Share (USD) (ttm) | 8.1400 |
| Est. EPS (USD) (12/2012) | 8.3770 |
| Est. PEG Ratio | 2.3605 |
| Market Cap (M CHF) | 18,778.66 |
| Shares Outstanding (M) | 118.78 |
| Enterprise Value (M USD) (ttm) | 17,075.80 |
| Enterprise Value/EBITDA (ttm) | 10.66 |
| Price/Book (mrq) | 2.6244 |
| Price/Sale (ttm) | 4.9053 |
| Dividend Indicated Gross Yield | 1.1385 |
| Next Earnings Announcement | 08/09/2012 |
More SYST Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for SYST
- Operating
- Investing
- Financing (M/USD)
Company Profile & Key Executives for SYST
Synthes, Inc. develops, manufactures, and sells products used in orthopedic trauma surgery. The Company's products include screws, plates, intramedullary nails, hip screw systems, external fixation devices, and power tools. Synthes's products are used in the operative treatment of fractures, deformities, tumors, and degenerative bone diseases.
| Hansjoerg WyssChairman | Charles HedgepethVice Chairman |
| Michel OrsingerPresident/CEO | Robert DonohueChief Financial Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page